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Background: Successful revascularization of chronic total occlusions (CTOs) remains one of the most difficult challenges for interventional 
cardiologists. Despite of improved long-term outcomes by drug-eluting stents (DES), however, there are limited data regarding outcomes of different 
DESs following CTO intervention.
Methods: A total 201 patients (pts) who underwent percutanous coronary intervention (PCI) with DESs for CTOs lesions were enrolled. We 
compared the angiographic and clinical outcomes of first generation DES [Paclitaxel-eluting stents (Taxus™) and Sirolimus-eluting stents (Cypher™)] 
to newer generation DESs [Zotarolimus-eluting stents (Endeavor Resolute™) and Everolimus-eluting stents (Promus Element™ or Xience™).
Results: Baseline clinical characteristics were similar between the two groups except that first generations DESs group had more smokers and 
dyslipidemia. At index procedure, first generation DESs showed a trend towards longer lesion length, more fluoroscopy time and higher amount of 
contrast. However, angiographic follow up at six months, there were no significant differences between the two groups. Similar results were found at 
twelve months clinical follow up (Table). 
Conclusions: In the current study, there were no significant differences between first and newer generations DESs at 6 months angiographic & 12 
months clinical outcomes following successful CTOs intervention.
Table. Six months angiographic and 12 months clinical outcomes 
Variables, n (%)
First generation DESs
(n=166 pts)
Newer generation DESs
(n=35 pts)
P-value
Angiographic outcome (6 Months):
Mean Diameter Stenosis (DS), % 26.41±20.9 22.63±23.6 0.284
Binary restenosis 22 (13.9) 7 (11.5) 0. 632
Follow up MLD 2.18±0.73 2.25±0.75 0.534
Clinical outcome (12 Months): 
Total death 5 (3.2) 0 (0) 0.498
Cardiac death 1 (0.6) 0 (0) 0.765
Non cardiac death 3 (1.9) 0 (0) 0.602
Myocardial infarction 2 (1.3) 0 (0) 0.671
TLR 18 (11.5) 2 (14.3) 0.753
TVR 22 (14) 2 (14.3) 0.978
All MACE 29 (18.5) 4 (28.60 0.359
TLR MACE 18 (11.5) 2 (14.3) 0.753
TVR MACE 27 (17.2) 2 (14.3) 0.781
